Taiba Healthcare

Taiba Healthcare is a major regional healthcare marketing, distribution, and retail group headquartered in Muscat, Oman, with a strong focus on rare disease medicines, innovative therapies, and improving access to care in the Middle East and Africa. The company has a commercial-stage rare disease portfolio, including exclusive distribution of select advanced therapies such as mavorixafor for WHIM syndrome, and is actively investing in advanced modalities like CAR T-cell therapy through strategic partnerships. Taiba positions itself as a leader in rare disease access in the region, with a broad product portfolio, health management solutions, and a strong emphasis on patient well-being, quality, and international regulatory compliance.